Bionano Genomics, Inc. (BNGO) by event type
BNGO moves most on analyst downgrades — a median of -1.92% at 30 minutes across 10 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the BNGO overview →
How BNGO reacts across 2 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst downgrades 2,526 of 2,603 | 10 | -1.92% | 0% | -0.61% |
| Rating reiterations 3,501 of 3,522 | 12 | -1.65% | 8% | +2.10% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 4 further classes were observed with fewer than 10 measured events and are not published.
That’s how BNGO usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst downgrades → · Rating reiterations → · BNGO overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Theravance Biopharma, Inc. - Ordinary Shares (TBPH) | 326 | +0.10% | 57% |
| Verona Pharma plc - American Depositary Shares (VRNA) | 325 | -0.03% | 39% |
| Wave Life Sciences, Inc. (WVE) | 321 | -0.14% | 45% |
| Pulse Biosciences, Inc (PLSE) | 320 | +0.18% | 55% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.